Inventor
LIN HERBERT Y
US22 patents
⚠️ This page may combine multiple inventors who share the name “LIN HERBERT Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WHITEHEAD BIOMEDICAL INST
5 patentsUS6010872AJan 4, 2000
Recombinant production of TGF-β type III receptor (betaglycan) polypeptides
WHITEHEAD BIOMEDICAL INST25 citations92
US6008011ADec 28, 1999
TGF-β type II receptor cDNAs
WHITEHEAD BIOMEDICAL INST34 citations92
US6001969ADec 14, 1999
Recombinant TGF-β type II receptor polypeptides
WHITEHEAD BIOMEDICAL INST40 citations92
US6046157AApr 4, 2000
Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides
WHITEHEAD BIOMEDICAL INST12 citations81
US6086867AJul 11, 2000
Modulation of TGF-β by TGF-β type III receptor polypeptides
WHITEHEAD BIOMEDICAL INST8 citations73
LIN HERBERT Y
4 patentsUS8637023B2Jan 28, 2014
Hemojuvelin fusion proteins
LIN HERBERT Y39 citations96
US8293236B2Oct 23, 2012
Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism
LIN HERBERT Y31 citations94
US8895002B2Nov 25, 2014
Hemojuvelin fusion proteins and uses thereof
LIN HERBERT Y8 citations83
US9708379B2Jul 18, 2017
Compositions for regulating iron homeostasis and methods of using same
LIN HERBERT Y7 citations76
NAKAYAMA TOMOKO
3 patentsUS8268799B2Sep 18, 2012
Compositions and methods for inhibiting expression of the HAMP gene
NAKAYAMA TOMOKO10 citations91
US8470799B2Jun 25, 2013
Compositions and methods for inhibiting expression of the HAMP gene
NAKAYAMA TOMOKO9 citations83
US8163711B2Apr 24, 2012
Compositions and methods for inhibiting expression of the HAMP gene
NAKAYAMA TOMOKO5 citations72
ALNYLAM PHARMACEUTICALS INC
3 patentsUS8791250B2Jul 29, 2014
Compositions and methods for inhibiting expression of the HAMP gene
ALNYLAM PHARMACEUTICALS INC7 citations84
US9090895B2Jul 28, 2015
Compositions and methods for inhibiting expression of the HAMP gene
ALNYLAM PHARMACEUTICALS INC1 citations63
US9506067B2Nov 29, 2016
Compositions and methods for inhibiting expression of the HAMP gene
ALNYLAM PHARMACEUTICALS INC0 citations52
MASSACHUSETTS GEN HOSPITAL
3 patentsUS9556251B2Jan 31, 2017
Methods and compositions to regulate hepcidin expression
MASSACHUSETTS GEN HOSPITAL6 citations83
US10611820B2Apr 7, 2020
Nucleic acids encoding hemojuvelin fusion proteins and uses thereof
MASSACHUSETTS GEN HOSPITAL0 citations51
US9758567B2Sep 12, 2017
Hemojuvelin fusion proteins and uses thereof
MASSACHUSETTS GEN HOSPITAL0 citations51